Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pardes Biosciences Inc.

    NASDAQ: PRDS · Real-Time Price · USD
    2.18
    0.02 (0.93%)
    At close: Aug 30, 2023, 7:59 PM

    Pardes Biosciences Statistics

    Share Statistics

    Pardes Biosciences has 62.01M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 62.01M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 179,735

    FTD / Avg. Volume

    n/a
    		 35.26%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1.05 and the forward PE ratio is null. Pardes Biosciences's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -1.05

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.55

    P/FCF Ratio

    n/a
    		 -1.36

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Pardes Biosciences has an Enterprise Value (EV) of 38.95M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.42

    EV / EBIT

    n/a
    		 -0.54

    EV / FCF

    n/a
    		 -0.54

    Financial Position

    The company has a current ratio of 9.81, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 9.81

    Quick Ratio

    n/a
    		 9.81

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -31.36

    Financial Efficiency

    Return on Equity is -51.86% and Return on Invested Capital is -53.57%.

    Return on Equity

    n/a
    		 -51.86%

    Return on Assets

    n/a
    		 -46.58%

    Return on Invested Capital

    n/a
    		 -53.57%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,639,491.23

    Employee Count

    n/a
    		 57

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -3.18M

    Effective Tax Rate

    n/a
    		 3.29%

    Stock Price Statistics

    The stock price has increased by 0.93% in the last 52 weeks. The beta is 0.42, so Pardes Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.42

    52-Week Price Change

    n/a
    		 0.93%

    50-Day Moving Average

    n/a
    		 2.07

    200-Day Moving Average

    n/a
    		 1.74

    Relative Strength Index (RSI)

    n/a
    		 70.03

    Average Volume (20 Days)

    n/a
    		 509,687

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -99.82M

    Net Income

    n/a
    		 -93.45M

    EBITDA

    n/a
    		 -93.45M

    EBIT

    n/a
    		 -93.45M

    Earnings Per Share (EPS)

    n/a
    		 -1.61
    Full Income Statement

    Balance Sheet

    The company has 59.28M in cash and 0 in debt, giving a net cash position of 59.28M.

    Cash & Cash Equivalents

    n/a
    		 59.28M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -148.16M

    Total Assets

    n/a
    		 157.31M

    Working Capital

    n/a
    		 155.38M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -71.98M and capital expenditures 0, giving a free cash flow of -71.98M.

    Operating Cash Flow

    n/a
    		 -71.98M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -71.98M

    FCF Per Share

    n/a
    		 -1.24
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PRDS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -95.13%

    FCF Yield

    n/a
    		 -73.27%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PRDS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 41.26

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist